My watch list  


Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of Health economics. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life) of a pharmaceutical product. We can distinguish several types of pharmacoeconomic evaluation:cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.

One important consideration in a pharmacoeconomic evaluation is to decide the perspective from which the analysis should be conducted (such as institutional or societal).

A complete compilation of cost-utility analyses in the peer reviewed medical literature is available at the The CEA Registry Website.

See also

  • Cost-minimization analysis
  • Cost-effectiveness analysis
  • Cost-benefit analysis
  • QALY
  • Cost-utility analysis
  • Perspective (pharmacoeconomic)

  • HealthEconomics.Com
  • Health Economics and Pharmacoeconomics Glossary of Terms - maintained by the University of Groningen, the Netherlands
  • Expert Review of Pharmacoeconomics and Outcomes Research - Peer-reviewed journal published by Future Science Group
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pharmacoeconomics". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE